Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Piper Sandler analyst Paul Newsome upgraded Metlife Inc (NYSE:MET) from Neutral to Overweight and raised the price target from $99 to $110. MetLife closed at $96.64 on Monday. See how other analysts view this stock.
- Northcoast Research analyst Jim Sanderson upgraded Brinker International Inc (NYSE:EAT) from Neutral to Buy and announced a $275 price target. Brinker International shares closed at $200.30 on Friday. See how other analysts view this stock.
- Keybanc analyst Steve Barger upgraded Plexus Corp (NASDAQ:PLXS) from Sector Weight to Overweight and announced a $300 price target. Plexus closed at $252.36 on Monday. See how other analysts view this stock.
- Morgan Stanley analyst Kallum Titchmarsh upgraded West Pharmaceutical Services Inc (NYSE:WST) from Equal-Weight to Overweight and boosted the price target from $365 to $400. West Pharmaceutical shares closed at $361.78 on Monday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Olivia Brayer Saunders upgraded Omeros Corp (NASDAQ:OMER) from Neutral to Overweight and announced a $22 price target. Omeros closed at $18.49 on Monday. See how other analysts view this stock.
Considering buying PLXS stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment